Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research led by scientists at the University of Pittsburgh and Mass Eye and Ear, a member of the Mass General Brigham health care system, and published in the journal BMJ Oncology.
Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research led by scientists at the University of Pittsburgh and Mass Eye and Ear, a member of the Mass General Brigham health care system, and published in the journalThe findings should provide reassurance to patients and clinicians who may hesitate to prescribe the medications because they are known to increase the...
The new findings were from the Systemic Immunosuppressive Therapy for Eye Diseases Cohort, which began two decades ago when principal investigator John Kempen, M.D., Ph.D.
The research team tracked each participant for an average of 10 years after they took immunosuppressant medications, or for a similar amount of time for those not taking immunosuppression, to see if they ever developed cancer. Four different categories of immunosuppressants—TNF-inhibitors, antimetabolites, alkylating agents and calcineurin inhibitors—were covered by the study, with some patients taking more than one type. Patients were on the medications for a median of one year.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Preston's fancy new restaurant with 'beef ribs to die for'Customers are also saying it is relatively affordable for a high end establishment
Lire la suite »
MAAP Women’s Short Team Bib EvoGreat for those who prefer a shorter leg length, but a little see-through and very pricey
Lire la suite »